Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
651-01-013 / 651-01-013 ISMRM Abstract

MRI-based Radiomics and Deep Learning for Guiding Fertility-Preserving Treatment in Endometrial Cancer

Primary: Body - Uterus
Secondary: Acquisition & Reconstruction - AI methods
651-01-013 · Pelvic MRI: Bladder, Endometrium, and Rectum · Thursday, 14 May, 8:30 AM–10:06 AM · Power Pitch Theatre 1
651-01-013 · Pelvic MRI: Bladder, Endometrium, and Rectum · Thursday, 14 May, 8:30 AM–10:06 AM · Power Pitch Theatre 1
Keywords: Radiomics Magnetic resonance imaging Endometrial Cancer Deep learning Fertility-preserving treatment
Accepted
Yuhan Fang 1,2, Le Fu2,3, Jiejun Cheng1,2
1Radiology, The First Maternal and Child Health Hospital of Shanghai, Shanghai, China
2Radiology, Shanghai first maternity and infant hospital, Shanghai, China
3The First Maternal and Child Health Hospital of Shanghai, Shanghai, China
Presenting Author: Yuhan Fang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. BRAY F, LAVERSANNE M, SUNG H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-63.
2. XIA C, DONG X, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants [J]. Chinese Medical Journal, 2022, 135(5): 584-90.
3. HAO M, HOU Y. Fertility-sparing treatment for endometrial cancer [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2025, 41(03): 280-4.
4. LIN G, NG K-K, CHANG C-J, et al. Myometrial Invasion in Endometrial Cancer: Diagnostic Accuracy of Diffusion-weighted 3.0-T MR Imaging—Initial Experience [J]. Radiology, 2009, 250(3): 784-92.
5. SAKANE M, HORI M, ONISHI H, et al. Assessment of Myometrial Invasion in Premenopausal Grade 1 Endometrial Carcinoma: Is Magnetic Resonance Imaging a Reliable Tool in Selecting Patients for Fertility-Preserving Therapy? [J]. Journal of Computer Assisted Tomography, 2018, 42(3): 412-7.
6. LIN G, HUANG Y T, CHAO A, et al. Influence of menopausal status on diagnostic accuracy of myometrial invasion in endometrial cancer: diffusion-weighted and dynamic contrast-enhanced MRI at 3 T [J]. Clinical Radiology, 2015, 70(11): 1260-8.
7. RODOLAKIS A, SCAMBIA G, PLANCHAMP F, et al. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma†,‡ [J]. Human Reproduction Open, 2023, 2023(1).
8. YANG J, LIU Y, LIU X, et al. MRI-based intratumoral and peritumoral radiomics for assessing deep myometrial invasion in patients with early-stage endometrioid adenocarcinoma [J]. Front Oncol, 2024, 14: 1474427.
9. ZHAO M, WEN F, SHI J, et al. MRI-based radiomics nomogram for the preoperative prediction of deep myometrial invasion of FIGO stage I endometrial carcinoma [J]. Med Phys, 2022, 49(10): 6505-16.
10. MA X L, CAI S Q, QIANG J W, et al. [Nomogram based on clinical and DCE-MRI characteristics for predicting the depth of myometrial invasion and grade of endometrioid endometrial carcinoma] [J]. Zhonghua Fu Chan Ke Za Zhi, 2025, 60(3): 202-15.
11. DENG Y, ZHAO T, ZHANG J, et al. Development of a nomogram based on whole-tumor multiparametric MRI histogram analysis to predict deep myometrial invasion in stage I endometrioid endometrial carcinoma preoperatively [J]. Acta Radiol, 2025, 66(1): 50-61.
12. MA X, CAI S, LU J, et al. The Added Value of ADC-based Nomogram in Assessing the Depth of Myometrial Invasion of Endometrial Endometrioid Adenocarcinoma [J]. Acad Radiol, 2024, 31(6): 2324-33.
13. FENG W, QU M, XIONG Y, et al. Combining intratumoral and peritumoral multimodality magnetic resonance imaging (MRI) to predict the expression level of human epidermal growth factor receptor-2 (HER-2) in breast cancer [J]. Clinical Radiology, 2025, 90.
14. YAN B, ZHAO T, DENG Y, et al. Intratumoral and peritumoral multiparametric MRI-based radiomics nomogram for preoperative risk stratification in patients with endometrial cancer [J]. Front Oncol, 2025, 15: 1572784.
15. REN J, CUI T, LI X, et al. Integrative intratumoral and peritumoral radiomic model for predicting endometrial cancer grade [J]. Oncol Lett, 2025, 30(4): 482.
16. LI J, MA D, CHEN X, et al. Predicting recurrence risk in endometrial cancer: a multisequence MRI intratumoral and peritumoral radiomics nomogram approach [J]. Front Oncol, 2025, 15: 1569729.
17. LIN Q, LU R, CHEN Y, et al. Retrospective analysis of metabolism-related genes in endometrial carcinoma: links to prognosis and immunity [J]. Journal of Obstetrics and Gynaecology, 2025, 45(1): 2572335.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/651-01-013